Prehabilitation for Ovarian Cancer Patients

Recruiting N/A Interventional Study
Prehabilitation Exercise Frailty Ovarian Cancer Surgical Complication Treatment Outcomes Enhanced Recovery After Surgery
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Supportive Care
Participants needed
108 (estimated)
Sponsor
Nova Scotia Health Authority · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Individuals with ovarian cancer have very poor survival rates. This is because the cancer is not usually detected until it has reached advanced stages. How long an individual survives also is determined by the cancer treatment they receive. Although there are best treatment practices to improve survival, some women have other conditions that limit treatment options. One such condition seen in as m…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18 years or older * Have a confirmed diagnosis of stage III or IV ovarian cancer * Scheduled to receive cytoreductive surgery as part of their treatment plan * Must have a minimum of 4-weeks between the time of study enrollment and scheduled surgery * Be able to attend in-pers…
Contacts

Scott Grandy, PhD

902-494-1145

grandy@dal.ca

CONTACT